Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease
Open Access
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 65 (6) , 2279-2289
- https://doi.org/10.1111/j.1523-1755.2004.00648.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal DiseaseCirculation, 2002
- Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysisKidney International, 2001
- Elevated plasma F2-isoprostanes in patients on long-term hemodialysisKidney International, 2001
- IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000American Journal of Kidney Diseases, 2001
- Iron and cardiac disease in the end-stage renal disease settingAmerican Journal of Kidney Diseases, 1999
- Saccharated Ferric Oxide-Induced Osteomalacia in Japan: Iron-Induced Osteopathy Due to Nephropathy.Endocrine Journal, 1998
- Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritisKidney International, 1989
- New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system.Journal of Clinical Investigation, 1987
- Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction.Journal of Clinical Investigation, 1976
- Reduced bactericidal capacity of polymorphs in iron deficiency.Archives of Disease in Childhood, 1973